在中国的癌症发病率和死亡率,2022年
Bingfeng Han1, Rongshou Zheng1, Hongmei Zeng1
1Office for Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Journal of the National Cancer Center
|July 22, 2024
概括
中国中国中国中国.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 中国国家癌症中心 (NCC) 报告了全国癌症统计数据.
- 国际癌症研究机构 (IARC) 发布了全球癌症负担数据.
- 在GLOBOCAN 2022中,NCC和IARC合作,在中国癌症负担数据发布方面保持一致.
研究的目的:
- 估计2022年中国的癌症发病率和死亡率.
- 分析2000-2018年癌症发病率和死亡率的时间趋势.
- 为癌症预防和控制策略提供信息.
主要方法:
- 利用来自中国700家癌症登记处 (2018年) 的数据.
- 建立了一个使用106个连续注册表 (2010-2018) 的年龄周期队列模型.
- 分析了使用22个连续癌症登记 (2000-2018) 数据的时间趋势.
主要成果:
- 在中国 (2022年) 估计有482万例新增癌症病例和257万例死亡.
- 肺癌,结肠直肠癌,甲状腺癌,肝癌和胃癌在发病率方面排名前五.
- 肺癌,肝癌,胃癌,结肠直肠癌和食道癌导致癌症死亡.
- 根据年龄标准化的总体发病率 (ASIR) 每年增加1.4% (2000-2018).
- 总体年龄标准化死亡率 (ASMR) 每年减少1.3% (2000-2018).
- 观察到食道,胃和肝癌的下降趋势;甲状腺,前列腺和宫癌的增加趋势.
结论:
- 在中国,癌症仍然是一个重要的公共卫生问题.
- 预防和控制措施降低了某些癌症的发病率/死亡率.
- 对风险因素控制,查和治疗的持续努力对于减轻未来的癌症负担至关重要.
相关概念视频
Cancer Survival Analysis
336
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
336
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Actuarial Approach
71
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
71
What is Cancer?
10.6K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.6K
Cancers Originate from Somatic Mutations in a Single Cell
11.8K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K


